30,932 Shares in Celanese Corporation $CE Purchased by AXQ Capital LP

AXQ Capital LP bought a new stake in shares of Celanese Corporation (NYSE:CE) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 30,932 shares of the basic materials company’s stock, valued at approximately $1,302,000. Celanese comprises about 0.5% of AXQ Capital LP’s portfolio, making the stock its 28th biggest holding.

Other hedge funds and other institutional investors have also made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Celanese by 41.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 32,450 shares of the basic materials company’s stock valued at $1,842,000 after purchasing an additional 9,543 shares in the last quarter. NewEdge Advisors LLC lifted its stake in shares of Celanese by 265.2% in the first quarter. NewEdge Advisors LLC now owns 5,032 shares of the basic materials company’s stock worth $286,000 after buying an additional 3,654 shares in the last quarter. AlphaQuest LLC boosted its position in Celanese by 1,163.8% during the second quarter. AlphaQuest LLC now owns 8,076 shares of the basic materials company’s stock worth $447,000 after acquiring an additional 7,437 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in Celanese by 30.6% during the 2nd quarter. Nisa Investment Advisors LLC now owns 37,986 shares of the basic materials company’s stock valued at $2,102,000 after acquiring an additional 8,910 shares in the last quarter. Finally, Envestnet Asset Management Inc. raised its holdings in Celanese by 4.6% in the 2nd quarter. Envestnet Asset Management Inc. now owns 75,190 shares of the basic materials company’s stock valued at $4,160,000 after acquiring an additional 3,311 shares during the last quarter. Hedge funds and other institutional investors own 98.87% of the company’s stock.

Celanese Price Performance

Celanese stock opened at $52.26 on Tuesday. The company’s 50 day simple moving average is $47.70 and its 200-day simple moving average is $44.20. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.94 and a current ratio of 1.55. Celanese Corporation has a 1 year low of $35.13 and a 1 year high of $63.55. The company has a market capitalization of $5.72 billion, a price-to-earnings ratio of -4.93 and a beta of 1.12.

Celanese (NYSE:CE) last posted its earnings results on Tuesday, February 17th. The basic materials company reported $0.67 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.22). Celanese had a negative net margin of 12.15% and a positive return on equity of 8.75%. The company had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.25 billion. During the same quarter last year, the business posted $1.45 EPS. The firm’s revenue for the quarter was down 6.5% on a year-over-year basis. Celanese has set its Q1 2026 guidance at 0.700-0.850 EPS. As a group, equities research analysts expect that Celanese Corporation will post 8.79 earnings per share for the current year.

Celanese Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 24th will be paid a dividend of $0.03 per share. The ex-dividend date of this dividend is Tuesday, February 24th. This represents a $0.12 annualized dividend and a yield of 0.2%. Celanese’s dividend payout ratio is presently -1.13%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on CE shares. Tudor Pickering upgraded Celanese from a “strong sell” rating to a “hold” rating in a report on Tuesday, November 11th. Zacks Research downgraded Celanese from a “hold” rating to a “strong sell” rating in a research report on Tuesday, January 20th. Robert W. Baird set a $65.00 target price on Celanese in a report on Thursday. Morgan Stanley initiated coverage on Celanese in a report on Tuesday, January 20th. They set an “equal weight” rating and a $50.00 price target on the stock. Finally, Citigroup upped their price objective on shares of Celanese from $63.00 to $75.00 and gave the company a “buy” rating in a report on Thursday. Seven research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $59.72.

Insider Buying and Selling

In other news, CFO Chuck Kyrish bought 5,000 shares of the company’s stock in a transaction on Tuesday, December 9th. The stock was bought at an average cost of $41.03 per share, with a total value of $205,150.00. Following the transaction, the chief financial officer directly owned 10,914 shares in the company, valued at $447,801.42. The trade was a 84.55% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.26% of the stock is owned by company insiders.

Celanese Company Profile

Celanese Corporation is a global chemical and specialty materials company that develops, manufactures and markets a broad portfolio of products serving diverse industries. The company operates through two primary business segments—Engineered Materials and Acetyl Chain—offering solutions that range from high-performance polymers and specialty additives to industrial chemicals and intermediates. Its engineered materials are used in applications such as automotive components, consumer electronics, medical devices and packaging, while its acetyl derivatives find uses in coatings, adhesives, solvents and personal care products.

In the Engineered Materials segment, Celanese produces a variety of high-performance thermoplastics, polyether-block-amide (PEBA) elastomers and functional additives designed to enhance product durability, thermal resistance and sustainability.